Black Diamond Therapeutics (BDTX) Treasury Shares: 2018-2020
Historic Treasury Shares for Black Diamond Therapeutics (BDTX) over the last 2 years, with Dec 2020 value amounting to $18,120.
- Black Diamond Therapeutics' Treasury Shares fell 48.31% to $30,667 in Q3 2021 from the same period last year, while for Sep 2021 it was $30,667, marking a year-over-year decrease of 48.31%. This contributed to the annual value of $18,120 for FY2020, which is N/A change from last year.
- According to the latest figures from FY2020, Black Diamond Therapeutics' Treasury Shares is $18,120, which was down 86.34% from $132,645 recorded in FY2018.
- In the past 5 years, Black Diamond Therapeutics' Treasury Shares registered a high of $132,645 during FY2018, and its lowest value of $18,120 during FY2020.
- Moreover, its 2-year median value for Treasury Shares was $75,382 (2018), whereas its average is $75,382.